Proteomics

Dataset Information

0

Secretome analysis of primary CLL cells


ABSTRACT: Secretome analysis of primary CLL cells co-cultured in serum-free IMDM medium with either EL08 stroma cells or YK6 follicular dendritic cells overexpressing CD40L and interleukin 21 (“FDC CD40L IL21”).

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Primary Cell Line

DISEASE(S): Acute Leukemia

SUBMITTER: Piero Giansanti  

LAB HEAD: Piero Giansanti

PROVIDER: PXD069904 | Pride | 2026-01-22

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.

Soberón Valeria V   Osswald Lena L   Moore Andrew A   Sosnowska Dominika D   Swinerd Gene G   Chen Jingyu J   Baygün Seren S   Diehl Carina C   Seyhan Gönül G   Kraus Laura L   Gölling Vanessa V   Trapp Ricarda R   O'Neill Thomas J TJ   Bortoluzzi Sabrina S   Kovacs Daniel D   Ammon Tim T   Singroul Pankaj P   Hubarzhevska Yuliia Y   Öllinger Rupert R   Mueller Sebastian S   Baranov Olga O   Giansanti Piero P   Gillhuber Felix F   Grath Sonja S   Weigert Oliver O   Rosenwald Andreas A   Sasaki Yoshiteru Y   Rajewsky Klaus K   Steiger Katja K   Bassermann Florian F   Rad Roland R   Krappmann Daniel D   Ringshausen Ingo I   Schmidt-Supprian Marc M  

Leukemia 20260116


Aberrant activation of NF-κB transcription factors is a hallmark of human lymphomas. Most lymphoma-intrinsic as well as microenvironment-induced NF-κB activation occurs upstream of the key kinase IKK2, therefore affecting additional pathways. Here, we show that canonical NF-κB signaling in mouse B cells, induced through the expression of one or two copies of a constitutively active IKK2 variant, dose-dependently drives lymphomagenesis. The observed phenotype and stereotypic B cell receptor clona  ...[more]

Similar Datasets

2022-05-26 | PXD030339 | Pride
2022-06-09 | PXD030340 | Pride
2025-09-09 | PXD062119 | Pride
2024-05-02 | PXD047017 | Pride
2024-05-02 | PXD047090 | Pride
2024-05-02 | PXD046952 | Pride
2019-09-16 | PXD014410 | Pride
2023-05-10 | PXD038281 | Pride
2021-08-26 | PXD027160 | Pride
2021-08-26 | PXD027162 | Pride